HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.

A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they liveThe Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) ...

The US's decision to halt most foreign aid this year has been a “systemic shock” to the fight against AIDS, according to ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.

Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

Africa Check has debunked viral social media claims about an HIV “cure”, clarifying that the breakthrough is promising, but ...